A New Study on Medication Abortion Refutes the Arguments Conservatives Are Taking to the Supreme Court

A study of more than 6,000 medication abortions obtained through telehealth found 98 percent were effective and 99.8 percent were safe.

Feb 16, 2024

A key argument from anti-abortion activists bringing a case to the Supreme Court is that medication abortion—which accounts for more than half of all abortions nationwide, according to the Guttmacher Institute—is unsafe and ineffective.

A new study provides even more evidence that this is not true and that medication abortion is just as safe when it’s prescribed virtually as in person. Published Thursday in the journal Nature Medicine, the study examined more than 6,000 medication abortions that people from 20 states and Washington, D.C. obtained from three virtual clinics between April 2021 and January 2022. Researchers found that about 98 percent of them were effective in terminating pregnancies without any additional interventions and that 99.8 percent were safe and “not followed by serious adverse events.”

Continued: https://www.motherjones.com/politics/2024/02/a-new-study-on-medication-abortion-refutes-the-arguments-conservatives-are-taking-to-the-supreme-court/

Post-Roe v. Wade, more patients rely on early prenatal testing as states toughen abortion laws

by: LAURA UNGAR and AMANDA SEITZ, Associated Press
Feb 12, 2024

WASHINGTON (AP) — In Utah, more of Dr. Cara Heuser’s maternal-fetal medicine patients are requesting early ultrasounds, hoping to detect serious problems in time to choose whether to continue the pregnancy or have an abortion.

In North Carolina, more obstetrics patients of Dr. Clayton Alfonso and his colleagues are relying on early genetic screenings that don’t provide a firm diagnosis.

The reason? New state abortion restrictions mean the clock is ticking.

Continued: https://www.westernslopenow.com/news/national-news/ap-post-roe-v-wade-more-patients-rely-on-early-prenatal-testing-as-states-toughen-abortion-laws/

USA – Dozens of ‘friend of the court’ briefs backing abortion pill access arrive at Supreme Court

FEBRUARY 2, 2024

WASHINGTON — The U.S. Supreme Court has been inundated with dozens of organizations seeking to weigh in on the future of the abortion pill by filing “friend of the court” briefs.

The groups include governors, attorneys general, state lawmakers and members of Congress as well as medical organizations, civil rights groups and pharmaceutical companies — all of whom argue the justices’ ruling will have significant effects on American society and health care.

“Turning back the clock to reimpose unnecessary restrictions on mifepristone will exacerbate existing inequities in maternal health for women of color, low-income women, and those living in rural areas,” wrote a group of more than 16 medical organizations, including the American College of Obstetricians and Gynecologists and The American Medical Association.

Continued: https://wisconsinexaminer.com/2024/02/02/dozens-of-friend-of-the-court-briefs-backing-abortion-pill-access-arrive-at-supreme-court/

Supreme Court mifepristone case will affect millions. Don’t base ruling off junk science.

Access to safe and effective medications like mifepristone should be based on rigorous scientific research and the medical community consensus – not the fringe opinions of a few extremists.

Julia Kaye
Jan 31, 2024

Overturning Roe v. Wade was just the beginning.

In Idaho v. United States, the question is whether states can disregard longstanding federal protections and bar doctors from providing abortions to patients experiencing medical emergencies.

The second case, Alliance for Hippocratic Medicine v. Food and Drug Administration, targets access to mifepristone, a safe and effective medication used in most abortions in this country and for miscarriage management. Since its FDA approval a quarter century ago, mifepristone has been safely used by more than 5 million people.

Continued: https://www.usatoday.com/story/opinion/voices/2024/01/31/supreme-court-abortion-pill-mifepristone-junk-science/72370445007/

Fear and confusion over abortion access persists as SCOTUS takes its first post-Dobbs case

Mifepristone will likely remain legal but could prove much harder to access. Legal and pharmaceutical experts have said this case could have far-reaching implications on approval for medications beyond abortion drugs.

DECEMBER 19, 2023

This year will end on a major cliffhanger for abortion access.

Last November, anti-abortion activists via a powerful conservative Christian law firm asked a federal court to effectively ban or widely restrict the abortion drug mifepristone. Finally on Wednesday, the U.S. Supreme Court agreed to take the case, making Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration the high court’s first abortion-related case since overturning the federal right to an abortion in June 2022.

Continued: https://www.thelundreport.org/content/fear-and-confusion-over-abortion-access-persists-scotus-takes-its-first-post-dobbs-case

The Abortion Pill Might Just Stand a Chance at the Supreme Court

In a sign that its recent regard for restraint is prevailing, the Roberts court is signaling that it’ll take a narrow approach on mifepristone.

Matt Ford
December 14, 2023

The Supreme Court announced on Wednesday that it would take up its first abortion-related case since overturning Roe v. Wade last year. Abortion rights groups could not have asked for a better start to it.

In its latest batch of orders, the court said it would take up FDA v. Alliance for Hippocratic Medicine and Danco Laboratories v. Alliance for Hippocratic Medicine. The consolidated appeals, which all stem from the same original lawsuit, seek to overturn a federal court’s ruling in Texas that, if allowed to take effect, would overturn recent Food and Drug Administration rule changes that made the most widely used abortion pill easier to prescribe and obtain.

Continued: https://newrepublic.com/article/177580/supreme-court-narrow-mifepristone-standing

The Supreme Court will hear its biggest abortion case since it overruled Roe v. Wade

The justices will decide whether to ban mifepristone, a drug used in half of US abortions.

By Ian Millhiser 
Dec 13, 2023

The Supreme Court announced on Wednesday that it will give a full hearing to a long-simmering dispute over whether far-right federal courts may ban the abortion drug mifepristone.

Mifepristone is part of a two-drug treatment that causes the uterus to expel pregnancy tissue. This two-drug regime, which may be taken up to the 70th day of a pregnancy, is often a safer alternative than surgical abortion — and it is also a less invasive procedure. More than half of all US abortions are medication abortions, which use mifepristone.

Continued: https://www.vox.com/scotus/2023/12/13/23992173/supreme-court-abortion-ban-mifepristone-danco-fda-alliance-hippocratic-medicine

Anti-abortion attorneys ascend federal government ranks with Christian right legal training

The conservative Christian law firm Alliance Defending Freedom’s expansive ties include federal judges and most recently Speaker of the House

DECEMBER 10, 2023

When Mississippi Solicitor General Scott G. Stewart presented Dobbs v. Jackson Women’s Health Organization to the U.S. Supreme Court in December 2021, he argued that state lawmakers should be able to ban abortion at any time in pregnancy, not just after so-called “viability,” the point where a fetus could survive outside of a uterus. The U.S. Constitution, he said, does not specifically protect the “purposeful termination of a human life.”

“The viability line discounts and disregards state interests,” Stewart said, according to the transcript of the oral arguments, contending that state lawmakers should be able to draw an earlier line on when they believe human life officially begins.

Continued: https://www.nevadacurrent.com/2023/12/10/anti-abortion-attorneys-ascend-federal-government-ranks-with-christian-right-legal-training/

Abortion pill mifepristone: An explainer and research roundup about its history, safety and future

Amid pending court cases and ballot initiatives, journalistic coverage of medication abortion has never been more crucial. This piece aims to help inform the narrative with scientific evidence.

by Naseem S. Miller
November 1, 2023

Access to mifepristone, a medication that’s used for the safe termination of early pregnancy, hangs in the balance while the U.S. Supreme Court decides whether to take up a case that could determine the legal future of the abortion medication.

In August, the 5th U.S. Circuit Court of Appeals ruled that mifepristone should not be prescribed past the seventh week of pregnancy, prescribed via telemedicine, or shipped to patients through the mail. In September, the Justice Department asked the Supreme Court to consider a challenge to that ruling.

Continued: https://journalistsresource.org/health/mifepristone-research-roundup/

USA – The right-wing’s opposition to abortion is not about saving or protecting women lives

by Jill Filipovic
November 1, 2023

A year and a half after Republican-appointed Supreme Court justices overturned Roe v. Wade and stripped the constitutional right to abortion from American women, the Republican Party has been floundering.

It turns out that the American public is broadly pro-choice, according to a CNN poll from August, and many voters are horrified by the predictable results of abortion bans: child rape victims unable to end dangerous pregnancies in their home states, women nearly dying of treatable pregnancy complications, mothers with much-wanted but tragically doomed pregnancies being denied the ability to choose how those pregnancies end.

Continued: https://www.cnn.com/2023/11/01/opinions/over-the-counter-birth-control-gop-filipovic/index.html